May 11
|
Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report
|
May 9
|
Myriad Genetics First Quarter 2024 Earnings: Beats Expectations
|
May 8
|
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
|
May 8
|
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
|
May 8
|
Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...
|
May 7
|
Myriad (MYGN) Reports Q1 Earnings: What Key Metrics Have to Say
|
May 7
|
Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
|
May 7
|
Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates
|
May 7
|
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
|
May 7
|
Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
|
May 7
|
Myriad Genetics (NASDAQ:MYGN) shareholders have endured a 26% loss from investing in the stock five years ago
|
Apr 30
|
Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024
|
Apr 24
|
Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
|
Apr 17
|
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor
|
Apr 16
|
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
|
Apr 11
|
Myriad Genetics (MYGN) Announces Favorable Research Results
|
Apr 9
|
Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing
|
Mar 29
|
Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?
|
Mar 28
|
Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?
|
Mar 27
|
Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay
|